Fund Holdings — Crestline Management, LP

Total Portfolio Value
$53.48M
Total Bought
$0
Total Sold
$6.70M
Net Transaction
-$6.70M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
DENALI THERAPEUTICS INC(DNLI)2,210,7321,910,732-300,00042,44649,14491.90%+6,698
SANA BIOTECHNOLOGY INC(SANA)755,736755,73602,1772,6384.93%+461
8X8 INC NEW(EGHT)990,850990,85001,6451,6943.17%+50
Page 1 of 1
Crestline Management, LP — 13F Holdings — Q2 2026 | TickerTrail